Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials

BACKGROUND: Immunosuppressive agents have been widely used in the treatment of IgA nephropathy (IgAN), but the efficacy and safety remain controversial. The recent STOP-IgAN and TESTING studies have again focused attention on the application of immunosuppressive agents in IgAN. This study investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zheng, Yang, Yue, Jiang, Shi-min, Li, Wen-ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710882/
https://www.ncbi.nlm.nih.gov/pubmed/31455248
http://dx.doi.org/10.1186/s12882-019-1519-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710882/
https://www.ncbi.nlm.nih.gov/pubmed/31455248
http://dx.doi.org/10.1186/s12882-019-1519-3

Ejemplares similares